Screener
Atossa Therapeutics, Inc. ATOS Q2 2026 earnings
Reported August 7, 2026 · Before market open
EPS-$0.95Beat by $0.07
EPS estimate-$1.02
Next report
Nov 11, 2026 (in 2 months)EPS estimate-$0.92
Versus estimates
Diluted EPS
FAQ
- When did Atossa Therapeutics, Inc. report Q2 2026 earnings?
- Atossa Therapeutics, Inc. (ATOS) reported Q2 2026 earnings on August 7, 2026 before market open.
- What were Atossa Therapeutics, Inc.'s Q2 2026 revenue and EPS?
- Atossa Therapeutics, Inc. reported eps of $-0.95 for Q2 2026.
- Did Atossa Therapeutics, Inc. beat estimates in Q2 2026?
- EPS beat the consensus estimate of $-1.02 by $0.07.
- How did Atossa Therapeutics, Inc.'s Q2 2026 results compare year-over-year?
- Compared to the same quarter a year prior, eps declined 1257.1% from $-0.07.
- Where can I find Atossa Therapeutics, Inc.'s Q2 2026 SEC filings?
- You can read the 8-K earnings release (0001193125-26-339292) and the 10-Q periodic report (0001193125-26-339257) directly on SEC EDGAR. The filing index links above go to sec.gov.
